Secondaries announced 7.8.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: Anthera Pharmaceuticals
Symbol: ANTH
Price: Last trade $8.32
Trade Date: 7/9
Shares: 3 million
Underwriter(s) Citigroup, Piper Jaffray
Rating=Subscription Needed